NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute AcquisitionKadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network of psychiatric...
GoInvest Staff
Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand GrowsIntelligent Bio Solutions remains on track for a 2025 U.S. launch of its non-invasive Intelligent Fingerprinting Drug...
NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Wall Street Conference on May 21NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that Founder and CEO Dr. Jonathan Javitt will...
SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) CEO Discusses Business Mode on GotStocks Podcast
SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) CEO Discusses Business Mode on GotStocks Podcast
SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) CEO Discusses Business Mode on GotStocks PodcastDisseminated on behalf of SolarBank Corporation CEO Dr. Richard Lu discussed SolarBank’s vertically integrated business model on...
Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health ReformRep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of Republican lawmakers...
SolarBank (NASDAQ: SUUN) (CSE: SUNN) Reports Q3 Results; Eyes Long-Term Gains with $100M Project FinancingDisseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) posted fiscal Q3 results for the period...
NATCOM: Celebrates Haitian Flag Day & Strengthens Global Haitian Connections via International Top-Up and Remittance ServicesPort-au-Prince, Haiti – 14 May 2025 – NATCOM proudly brings the image of the Haitian flag to the...
Intelligent Bio Solutions (NASDAQ: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive MarginsIntelligent Bio Solutions (NASDAQ: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported a 20% sequential...
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry InstituteNRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a definitive agreement to...
D-Wave Quantum (NYSE: QBTS) to Participate in Multiple Investor Conferences Through JuneD-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that it...
